TrialClinical pharmacology and therapeutics2022

Population Pharmacokinetic Modeling and Probability of Pharmacodynamic Target Attainment for Ceftazidime-Avibactam in Pediatric Patients Aged 3 Months and Older.

Richard C Franzese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.